- Home
- CHNR vs NLSP Comparison
CHNR vs NLSP Comparison
Compare CHNR & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHNR
- NLSP
- Stock Information
- Founded
- CHNR N/A
- NLSP 2015
- Country
- CHNR Hong Kong
- NLSP Switzerland
- Employees
- CHNR N/A
- NLSP N/A
- Industry
- CHNR Precious Metals
- NLSP Biotechnology: Pharmaceutical Preparations
- Sector
- CHNR Basic Materials
- NLSP Health Care
- Exchange
- CHNR Nasdaq
- NLSP Nasdaq
- Market Cap
- CHNR 6.4M
- NLSP 243.8M
- IPO Year
- CHNR 1995
- NLSP 2021
- Fundamental
- Price
- CHNR $0.79
- NLSP $4.55
- Analyst Decision
- CHNR
- NLSP
- Analyst Count
- CHNR 0
- NLSP 0
- Target Price
- CHNR N/A
- NLSP N/A
- AVG Volume (30 Days)
- CHNR 148.0K
- NLSP 33.1K
- Earning Date
- CHNR 01-01-0001
- NLSP 11-01-2024
- Dividend Yield
- CHNR N/A
- NLSP N/A
- EPS Growth
- CHNR N/A
- NLSP N/A
- EPS
- CHNR N/A
- NLSP N/A
- Revenue
- CHNR N/A
- NLSP N/A
- Revenue This Year
- CHNR N/A
- NLSP N/A
- Revenue Next Year
- CHNR N/A
- NLSP N/A
- P/E Ratio
- CHNR N/A
- NLSP N/A
- Revenue Growth
- CHNR N/A
- NLSP N/A
- 52 Week Low
- CHNR $0.55
- NLSP $4.08
- 52 Week High
- CHNR $8.85
- NLSP $29.84
- Technical
- Relative Strength Index (RSI)
- CHNR 53.35
- NLSP 40.59
- Support Level
- CHNR $0.68
- NLSP $4.38
- Resistance Level
- CHNR $0.83
- NLSP $5.64
- Average True Range (ATR)
- CHNR 0.10
- NLSP 0.47
- MACD
- CHNR -0.00
- NLSP 0.06
- Stochastic Oscillator
- CHNR 24.60
- NLSP 29.16
About CHNR China Natural Resources Inc.
China Natural Resources Inc is an investment holding company. It principally engaged in the exploration and mining and wastewater treatment businesses in the People's Republic of China. The company has two operating segments: (i) Wastewater treatment segment, which consists of sales of assembled equipment, provision of construction service, and participation in PPP projects as an operator (ii) Exploration and mining segment, which consists of the exploration of lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and the trading of copper ores products. It earns the majority of its revenue from the Wastewater treatment segment.
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.